Introduction Global estimates on numbers of persons in early stages of Alzheimer's disease
(AD), including prodromal and preclinical, are lacking, yet are needed to inform policy …

Introduction The estimate of people with clinical Alzheimer's disease (AD) and mild cognitive
impairment provides an understanding of the disease burden. Methods We estimated …

Background Alzheimer's disease (AD) profoundly affects the end-of-life experience. Yet,
counts of deaths attributable to AD understate this burden of AD in the population. Therefore …

Introduction We forecast the prevalence of preclinical and clinical Alzheimer's disease (AD)
and evaluated potential impacts of primary and secondary preventions in the United States …

Introduction Alzheimer's disease and related dementias (ADRD) cause a high burden of
morbidity and mortality in the United States. Age, race, and ethnicity are important risk …

Background With the increase in the aging population worldwide, Alzheimer's disease has
become a rapidly increasing public health concern. Monitoring the dementia disease burden …

This report provides information to increase understanding of the public health impact of
Alzheimer's disease (AD). Topics addressed include incidence, prevalence, mortality rates …

This article describes the public health impact of Alzheimer's disease (AD), including
incidence and prevalence, mortality rates, costs of care, and the overall impact on caregivers …

Background Given projected increases in population growth and population aging, the
number of people with dementia is expected to increase in the future. Characterizing the …

BACKGROUND/OBJECTIVES Population‐based incidence estimates of dementia and
Alzheimer disease (AD) provide important information for public health policy and resource …